Literature DB >> 20357788

Adverse effects of chronic opioid therapy for chronic musculoskeletal pain.

Leslie J Crofford1.   

Abstract

The use of opioids for the treatment of chronic pain has increased dramatically over the past decade. Whether these drugs provide considerable benefits in terms of pain reduction and improved function to balance the risks associated with their use, however, is unclear. Of particular importance to clinicians treating chronic musculoskeletal pain is opioid-induced hyperalgesia, the activation of pronociceptive pathways by exogenous opioids that results in central sensitization to pain. This phenomenon results in an increase in pain sensitivity and can potentially exacerbate pre-existing pain. Opioids also have powerful positive effects on the reward and reinforcing circuits of the brain that might lead to continued drug use, even if there is no abuse or misuse. The societal risk of increased opioid prescription is associated with increased nonmedical use, serious adverse events and death. Patients with chronic musculoskeletal pain should avoid the long-term use of opioids unless the benefits are determined to outweigh risks, in which case, the use of chronic opioids should be regularly re-evaluated.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20357788     DOI: 10.1038/nrrheum.2010.24

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN: 1759-4790            Impact factor:   20.543


  48 in total

Review 1.  Major increases in opioid analgesic abuse in the United States: concerns and strategies.

Authors:  Wilson M Compton; Nora D Volkow
Journal:  Drug Alcohol Depend       Date:  2005-07-14       Impact factor: 4.492

2.  An intravenous ketamine test as a predictive response tool in opioid-exposed patients with persistent pain.

Authors:  Steven P Cohen; Shuxing Wang; Lucy Chen; Connie Kurihara; Geselle McKnight; Matthew Marcuson; Jianren Mao
Journal:  J Pain Symptom Manage       Date:  2008-09-11       Impact factor: 3.612

3.  Source of drugs for prescription opioid analgesic abusers: a role for the Internet?

Authors:  Theodore J Cicero; Christopher Neil Shores; Alethea G Paradis; Matthew S Ellis
Journal:  Pain Med       Date:  2008-09       Impact factor: 3.750

Review 4.  Effectiveness of opioids in the treatment of chronic non-cancer pain.

Authors:  Andrea M Trescot; Scott E Glaser; Hans Hansen; Ramsin Benyamin; Samir Patel; Laxmaiah Manchikanti
Journal:  Pain Physician       Date:  2008-03       Impact factor: 4.965

5.  Placebo-induced changes in spinal cord pain processing.

Authors:  Dagfinn Matre; Kenneth L Casey; Stein Knardahl
Journal:  J Neurosci       Date:  2006-01-11       Impact factor: 6.167

6.  Beta-endorphin, Met-enkephalin and corresponding opioid receptors within synovium of patients with joint trauma, osteoarthritis and rheumatoid arthritis.

Authors:  Shaaban A Mousa; Rainer H Straub; Michael Schäfer; Christoph Stein
Journal:  Ann Rheum Dis       Date:  2007-02-26       Impact factor: 19.103

7.  Altered quantitative sensory testing outcome in subjects with opioid therapy.

Authors:  Lucy Chen; Charlene Malarick; Lindsey Seefeld; Shuxing Wang; Mary Houghton; Jianren Mao
Journal:  Pain       Date:  2009-02-23       Impact factor: 6.961

Review 8.  Oral or transdermal opioids for osteoarthritis of the knee or hip.

Authors:  Eveline Nüesch; Anne Ws Rutjes; Elaine Husni; Vivian Welch; Peter Jüni
Journal:  Cochrane Database Syst Rev       Date:  2009-10-07

9.  Evidence that opioids may have toll-like receptor 4 and MD-2 effects.

Authors:  Mark R Hutchinson; Yingning Zhang; Mitesh Shridhar; John H Evans; Madison M Buchanan; Tina X Zhao; Peter F Slivka; Benjamen D Coats; Niloofar Rezvani; Julie Wieseler; Travis S Hughes; Kyle E Landgraf; Stefanie Chan; Stephanie Fong; Simon Phipps; Joseph J Falke; Leslie A Leinwand; Steven F Maier; Hang Yin; Kenner C Rice; Linda R Watkins
Journal:  Brain Behav Immun       Date:  2009-08-11       Impact factor: 7.217

10.  Reversal of sleep-disordered breathing with opioid withdrawal.

Authors:  Kannan Ramar
Journal:  Pain Pract       Date:  2009-06-22       Impact factor: 3.183

View more
  50 in total

1.  Negative Affect-Related Factors Have the Strongest Association with Prescription Opioid Misuse in a Cross-Sectional Cohort of Patients with Chronic Pain.

Authors:  Gadi Gilam; John A Sturgeon; Dokyoung S You; Ajay D Wasan; Beth D Darnall; Sean C Mackey
Journal:  Pain Med       Date:  2020-02-01       Impact factor: 3.750

2.  Predictors of Improvements in Pain Intensity in a National Cohort of Older Veterans With Chronic Pain.

Authors:  Steven K Dobscha; Travis I Lovejoy; Benjamin J Morasco; Anne E Kovas; Dawn M Peters; Kyle Hart; J Lucas Williams; Bentson H McFarland
Journal:  J Pain       Date:  2016-04-04       Impact factor: 5.820

3.  Management of chronic pain in the rheumatic diseases with insights for the clinician.

Authors:  Mary-Ann Fitzcharles; Yoram Shir
Journal:  Ther Adv Musculoskelet Dis       Date:  2011-08       Impact factor: 5.346

4.  Suppression of inflammatory and neuropathic pain by uncoupling CRMP-2 from the presynaptic Ca²⁺ channel complex.

Authors:  Joel M Brittain; Djane B Duarte; Sarah M Wilson; Weiguo Zhu; Carrie Ballard; Philip L Johnson; Naikui Liu; Wenhui Xiong; Matthew S Ripsch; Yuying Wang; Jill C Fehrenbacher; Stephanie D Fitz; May Khanna; Chul-Kyu Park; Brian S Schmutzler; Bo Myung Cheon; Michael R Due; Tatiana Brustovetsky; Nicole M Ashpole; Andy Hudmon; Samy O Meroueh; Cynthia M Hingtgen; Nickolay Brustovetsky; Ru-Rong Ji; Joyce H Hurley; Xiaoming Jin; Anantha Shekhar; Xiao-Ming Xu; Gerry S Oxford; Michael R Vasko; Fletcher A White; Rajesh Khanna
Journal:  Nat Med       Date:  2011-06-05       Impact factor: 53.440

5.  Prescription Opioid Duration, Dose, and Increased Risk of Depression in 3 Large Patient Populations.

Authors:  Jeffrey F Scherrer; Joanne Salas; Laurel A Copeland; Eileen M Stock; Brian K Ahmedani; Mark D Sullivan; Thomas Burroughs; F David Schneider; Kathleen K Bucholz; Patrick J Lustman
Journal:  Ann Fam Med       Date:  2016 Jan-Feb       Impact factor: 5.166

6.  [Recommendations for symptomatic therapy of rheumatic pain with opioid analgetics].

Authors:  W W Bolten; S Reiter
Journal:  Z Rheumatol       Date:  2012-11       Impact factor: 1.372

7.  Pressure Pain Sensitivity in Patients With Suspected Opioid-Induced Hyperalgesia.

Authors:  Ronald A Wasserman; Afton L Hassett; Steven E Harte; Jenna Goesling; Herbert L Malinoff; Daniel W Berland; Jennifer Zollars; Stephanie E Moser; Chad M Brummett
Journal:  Reg Anesth Pain Med       Date:  2015 Nov-Dec       Impact factor: 6.288

8.  Involvement of delta opioid receptors in alcohol withdrawal-induced mechanical allodynia in male C57BL/6 mice.

Authors:  Doungkamol Alongkronrusmee; Terrance Chiang; Richard M van Rijn
Journal:  Drug Alcohol Depend       Date:  2016-08-21       Impact factor: 4.492

Review 9.  Medical and psychological risks and consequences of long-term opioid therapy in women.

Authors:  Beth D Darnall; Brett R Stacey; Roger Chou
Journal:  Pain Med       Date:  2012-08-20       Impact factor: 3.750

10.  Geographic variation of chronic opioid use in fibromyalgia.

Authors:  Jacob T Painter; Leslie J Crofford; Jeffery Talbert
Journal:  Clin Ther       Date:  2013-02-26       Impact factor: 3.393

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.